InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,427.13
(
-2.31%
)
US TECH 100
18,456.00
(
-0.43%
)
Dow Jones
39,853.87
(
-1.25%
)
Brent Oil
79.92
(
-1.02%
)
Bitcoin
64,168.34
(
-1.84%
)
Post# of 1645
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 38
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: bladerunner1717 post# 1476

Wednesday, 04/07/2021 2:27:03 PM

Wednesday, April 07, 2021 2:27:03 PM

Post# of 1645
Oppenheimer initiates coverage of ONCT with an "outperform" rating & a $14 price target.


--Analyst Actions: Oppenheimer Starts Oncternal Therapeutics at Outperform with $14 Price Target
BY MT Newswires
— 9:31 AM ET 04/07/2021
09:31 AM EDT, 04/07/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 9.06, Change: +0.40, Percent Change: +4.62


Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up